Through Project:EveryChild, Hyundai’s funds will help in the collection of biospecimens from children with cancer at COG institutions to be stored at the Hyundai COG Biorepository database, which provides doctors the ability to request and access thousands of cancer specimens and previous research.
Children’s Oncology Group, the world’s largest organization devoted to childhood and adolescent cancer research is leading Project:EveryChild’s research effort through children’s hospitals, universities, and cancer centers.
“Hyundai’s generous support to Project:EveryChild will make a significant difference in our ongoing battle against childhood cancer,” said Dr. Peter Adamson, Chairman of the Children’s Oncology Group. “This crucial funding will ensure that every child diagnosed with cancer in the U.S. will be eligible to participate in and benefit from the advances in research from Project:EveryChild, regardless of the rarity of the type of cancer.”
“Over the last 16 years we have been committed to reaching a day when no child will have to face cancer, and supporting COG’s Project:EveryChild is another big step in that direction,” said Dave Zuchowski, President and CEO of Hyundai Motor America and Board Member of Hyundai Hope On Wheels. “With the ability to study every child’s type of cancer, researchers will be able to more effectively collaborate and develop new and better treatments. And that’s something that all of us at Hyundai are extremely excited and passionate about.”